{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:37:27Z","timestamp":1777426647975,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.11.042","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T14:18:19Z","timestamp":1196777899000},"page":"292-300","source":"Crossref","is-referenced-by-count":84,"title":["Immune responses to polysaccharides: Lessons from humans and mice"],"prefix":"10.1016","volume":"26","author":[{"given":"\u00c1frica","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Faro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.11.042_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568005014605964","article-title":"Vaccines against polysaccharide antigens","volume":"1","author":"Lesinski","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.vaccine.2007.11.042_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","article-title":"B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms","volume":"176","author":"Vos","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2007.11.042_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/432582","article-title":"Carbohydrate moieties as vaccine candidates","volume":"41","author":"Lucas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.11.042_bib7","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/IAI.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","article-title":"Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults","volume":"185","author":"Goldblatt","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0009-8981(80)90252-1","article-title":"The serum IgG subclass levels in healthy infants of 13\u201362 weeks of age","volume":"101","author":"Zegers","year":"1980","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.vaccine.2007.11.042_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/CDLI.1.6.667-669.1994","article-title":"Placental transfer of immunoglobulin G subclasses","volume":"1","author":"Garty","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib11","first-page":"255","article-title":"Serum levels of IgG subclasses in the normal child. Evaluation by an immunoenzymatic method using monoclonal antibodies","volume":"45","author":"Aucouturier","year":"1988","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.vaccine.2007.11.042_bib12","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib13","series-title":"Clinical paediatrics and child health","author":"Candy","year":"2001"},{"key":"10.1016\/j.vaccine.2007.11.042_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1399-3038.2002.02088.x","article-title":"Evaluation of the relevance of humoral immunodeficiencies in a pediatric population affected by recurrent infections","volume":"13","author":"Finocchi","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(87)80012-4","article-title":"Splenic function: physiology and splenic hypofunction","volume":"7","author":"Sills","year":"1987","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib16","first-page":"45","article-title":"Prevention of infections in hyposplenic and asplenic patients: an update","volume":"62","author":"Melles","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1600-0609.2003.00158.x","article-title":"Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes","volume":"71","author":"Castagnola","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00418-006-0210-5","article-title":"The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants","volume":"126","author":"Steiniger","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib19","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.143.10.3200","article-title":"Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response","volume":"143","author":"Timens","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-3083.2005.01584.x","article-title":"Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines","volume":"61","author":"Breukels","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2007.11.042_bib22","unstructured":"Faro J. Modulaci\u00f3n meningoc\u00f3cica de la respuesta inmunitaria a ep\u00edtopos de Neisseria meningitidis. Doctoral Thesis. Universidad de Santiago de Compostela; 1986."},{"key":"10.1016\/j.vaccine.2007.11.042_bib23","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0140-6736(06)68703-5","article-title":"Pneumococcal vaccination in developing countries","volume":"367","author":"Levine","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.042_bib24","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1097\/01.inf.0000147654.03890.b9","article-title":"Meningococcal vaccines","volume":"23","author":"Danzig","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.11.042_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/spid.2002.125861","article-title":"Vaccines for the prevention of meningococcal disease in children","volume":"13","author":"Soriano-Gabarro","year":"2002","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/hv.1.4.2018","article-title":"Group C meningococcal polysaccharide\u2013tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology","volume":"1","author":"Pollabauer","year":"2005","journal-title":"Hum Vaccin"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2007.11.042_bib27","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"ACIP","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2007.11.042_bib28","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1016\/j.vaccine.2007.04.017","article-title":"Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"25","author":"Cook","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.60.5.673","article-title":"Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines","volume":"60","author":"Lepow","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.11.042_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults","volume":"19","author":"Borrow","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00123-06","article-title":"Priming for immunologic memory in adults by meningococcal group C conjugate vaccination","volume":"13","author":"Vu","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib33","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/S0264-410X(02)00318-3","article-title":"Prior meningococcal A\/C polysaccharide vaccine does not reduce immune responses to conjugate vaccine in young adults","volume":"20","author":"Lakshman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib34","first-page":"331","article-title":"Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines","volume":"77","author":"Position paper","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2007.11.042_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide\u2013protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/IAI.39.1.233-238.1983","article-title":"Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with thhe non-toxic protein CRM197","volume":"39","author":"Anderson","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/IAI.41.2.609-617.1983","article-title":"Immunological evaluation of meningococcal Group C polysaccharide\u2013tetanus toxoid conjugate in mice","volume":"41","author":"Beuvery","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib38","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.66.11.5450-5456.1998","article-title":"Murine immune responses to Neisseria meningitides group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine","volume":"66","author":"Rubinstein","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib39","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib40","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib41","unstructured":"WHO position paper. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. Wkly Epidemiol Rec 2006; 81:445\u201352."},{"key":"10.1016\/j.vaccine.2007.11.042_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.5.4.553","article-title":"Pneumococcal conjugate vaccines: emerging clinical information and its implications","volume":"5","author":"Lockhart","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.11.042_bib43","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2007.01.065","article-title":"Vaccines in the era of genomics: the pneumococcal challenge","volume":"25","author":"Barocchi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib44","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2006.09.027","article-title":"Brief review of the clinical effectiveness of PREVENAR against otitis media","volume":"25","author":"Fletcher","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.11.042_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.2006-0492","article-title":"National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States","volume":"118","author":"Grijalva","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.11.042_bib47","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.042_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.revmed.2006.08.004","article-title":"Pneumococcal vaccination: expected benefits in adults","volume":"28","author":"Temime","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.vaccine.2007.11.042_bib49","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/infdis\/173.4.1014","article-title":"Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults","volume":"173","author":"Powers","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib50","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.vaccine.2004.01.029","article-title":"Review of pneumococcal conjugate vaccine in adults: implications on clinical development","volume":"22","author":"Abraham-Van","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.11.042_bib52","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.vaccine.2006.02.010","article-title":"Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation","volume":"24","author":"De Wals","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.it.2004.11.004","article-title":"Vaccination against encapsulated bacteria in humans: paradoxes","volume":"26","author":"Weller","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib54","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.042_bib55","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/IAI.41.2.609-617.1983","article-title":"Immunological evaluation of meningococcal group C polysaccharide\u2013tetanus toxoid conjugate in mice","volume":"41","author":"Beuvery","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib57","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.66.11.5450-5456.1998","article-title":"Murine immune responses to Neisseria meningitidis group c capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine","volume":"66","author":"Rubinstein","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib58","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1016\/j.vaccine.2006.06.045","article-title":"Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model","volume":"24","author":"Shriner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib59","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1016\/j.vaccine.2006.04.033","article-title":"Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media","volume":"24","author":"Sabirov","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib60","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.vaccine.2006.09.021","article-title":"Pneumococcal vaccine animal model consensus group. Animal models for protein pneumococcal vaccine evaluation: a summary","volume":"25","author":"Steinhoff","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.042_bib61","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1172\/JCI115649","article-title":"Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations","volume":"89","author":"Adderson","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.11.042_bib62","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/IAI.70.8.4083-4091.2002","article-title":"Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F","volume":"70","author":"Zhou","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib63","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/eji.200526216","article-title":"Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection","volume":"35","author":"Koppel","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/intimm\/dxh089","article-title":"High- and low-affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin","volume":"16","author":"Galustian","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0008-8749(90)90233-H","article-title":"Serum antibody and cellular immune response in mice to dextran B512","volume":"131","author":"Fern\u00e1ndez","year":"1990","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/cimm.1994.1126","article-title":"Anti-IgM-Ficoll conjugates activate B cells from CBA but not CBA\/N mice","volume":"155","author":"Sverremark","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib67","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.4049\/jimmunol.135.6.4215","article-title":"Sequences of variable regions of hybridoma antibodies to alpha (1\u20136) dextran in BALB\/c and C57BL\/6 mice","volume":"135","author":"Sikder","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib68","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.4049\/jimmunol.149.7.2328","article-title":"Genetic mechanism for dominant VH gene expression. The VHB512 gene","volume":"149","author":"Fern\u00e1ndez","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.147.3.645","article-title":"Immunological unresponsiveness to native dextran B512 in young animals of dextran high responder strains is due to lack of Ig receptors expression. Evidence for a nonrandom expression of V-genes","volume":"147","author":"Fern\u00e1ndez","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-3083.1982.tb00725.x","article-title":"Ontogenic development of the suppressed secondary response to native dextran","volume":"16","author":"Wood","year":"1982","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/eji.1830160814","article-title":"The immune response to bacterial dextrans. Part III. Ontogenic development and strain distribution of specific clonal precursors","volume":"16","author":"Lundkvist","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3083.1980.tb00208.x","article-title":"A primary immune response to dextran B512 is followed by a period of antigen-specific immunosuppression caused by autoanti-idiotypic antibodies","volume":"11","author":"Fern\u00e1ndez","year":"1980","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib73","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1073\/pnas.76.11.5944","article-title":"Antigen-induced strain-specific autoantiidiotypic antibodies modulate the immune response to dextran B 512","volume":"76","author":"Fern\u00e1ndez","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.11.042_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-3083.1978.tb00493.x","article-title":"Immunological tolerance to the thymus-independent antigen dextran can be abrogated by thymus-dependent dextran conjugates: evidence against clonal deletion as the mechanism of tolerance induction","volume":"8","author":"M\u00f6ller","year":"1978","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/IAI.48.2.428-432.1985","article-title":"Immunoresponses to Neisseria meningitidis epitopes: primary versus secondary antiphosphorylcholine responses","volume":"48","author":"Faro","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib76","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.143.4.1259","article-title":"Antigenicity of dextran\u2013protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling","volume":"143","author":"Seppala","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/cimm.1994.1006","article-title":"Immune responses to bacterial polysaccharides: terminal epitopes are more immunogenic than internal structures","volume":"153","author":"Fern\u00e1ndez","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib78","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/IAI.51.1.224-232.1986","article-title":"Immunoresponses to Neisseria meningitidis epitopes: suppression of secondary response to phosphorylcholine is carrier specific","volume":"51","author":"Faro","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.042_bib79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00194889","article-title":"Immunoresponses to Neisseria meningitidis epitopes: in vivo analysis of immunocompetent cells involved in suppression of secondary response to phosphorylcholine","volume":"176","author":"Faro","year":"1987","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2567.1998.00612.x","article-title":"Unresponsiveness following immunization with the T-cell-independent antigen dextran B512. Can it be abrogated?","volume":"95","author":"Sverremark","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.11.042_bib81","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/intimm\/13.10.1213","article-title":"The response in old mice: positive and negative immune memory after priming in early age","volume":"13","author":"S\u00e1nchez","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2567.2004.01894.x","article-title":"Understanding thymus-independent antigen-induced reduction of thymus-dependent immune responses","volume":"112","author":"Lindroth","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.11.042_bib83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib84","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/intimm\/10.7.851","article-title":"Germinal center formation following immunization with the polysaccharide dextran B512 is substantially increased by cholera toxin","volume":"10","author":"Sverremark","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib85","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.164.12.6276","article-title":"The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects","volume":"164","author":"Agren","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib86","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1073\/pnas.91.7.2502","article-title":"Reaction of germinal centers in the T-cell-independent response to the bacterial polysaccharide alpha(1\u2013>6)dextran","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.11.042_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.immuni.2005.04.011","article-title":"B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae","volume":"23","author":"Haas","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2007.11.042_bib88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2004.06.019","article-title":"B1b lymphocytes confer T cell-independent long-lasting immunity","volume":"21","author":"Alugupalli","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2007.11.042_bib89","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1084\/jem.20061254","article-title":"High affinity germinal center B cells are actively selected into the plasma cell compartment","volume":"203","author":"Phan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib90","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.4049\/jimmunol.177.11.7723","article-title":"Imprinting the fate of antigen-reactive B cells through the affinity of the B-cell receptor","volume":"177","author":"O\u2019Connor","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib91","doi-asserted-by":"crossref","unstructured":"Lindroth K., Fern\u00e1ndez C. The role of Blim-1 in the GC reaction. Differential expression of Blimp-1 upon immunization with TD and TI antigens. Immunol Lett 2007; Aug 23; (Epub ahead of print).","DOI":"10.1016\/j.imlet.2007.07.018"},{"key":"10.1016\/j.vaccine.2007.11.042_bib92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2006.11.007","article-title":"Expression and function of toll-like receptors in T lymphocytes","volume":"19","author":"Kabelitz","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2007.11.042_bib93","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2174\/1566524054863898","article-title":"Targeted vaccine adjuvants based on modified cholera toxin","volume":"5","author":"Lycke","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2007.11.042_bib94","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.176.6.3697","article-title":"The combined CTA1-DD\/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells","volume":"176","author":"Helgeby","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0701345X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0701345X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T03:43:57Z","timestamp":1684122237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0701345X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X0701345X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}